Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 57

1.

Health and economic burden of influenza-associated illness in South Africa, 2013-2015.

Tempia S, Moyes J, Cohen AL, Walaza S, Edoka I, McMorrow ML, Treurnicht FK, Hellferscee O, Wolter N, von Gottberg A, Nguweneza A, McAnerney JM, Dawood H, Variava E, Cohen C.

Influenza Other Respir Viruses. 2019 Jun 11. doi: 10.1111/irv.12650. [Epub ahead of print]

2.

The impact of HIV exposure on respiratory syncytial virus-associated severe respiratory illness in South African infants, 2011-2016.

McMorrow ML, Tempia S, Walaza S, Treurnicht FK, Moyes J, Cohen AL, Pretorius M, Hellferscee O, Wolter N, von Gottberg A, Nguweneza A, McAnerney JM, Naby F, Mekgoe O, Venter M, Madhi SA, Cohen C.

Clin Infect Dis. 2019 Apr 9. pii: ciz288. doi: 10.1093/cid/ciz288. [Epub ahead of print]

PMID:
30963178
3.

The Impact of Influenza and Tuberculosis Interaction on Mortality Among Individuals Aged ≥15 Years Hospitalized With Severe Respiratory Illness in South Africa, 2010-2016.

Walaza S, Tempia S, Dawood H, Variava E, Wolter N, Dreyer A, Moyes J, Von Mollendorf C, McMorrow M, Von Gottberg A, Haffejee S, Venter M, Treurnicht FK, Hellferscee O, Martinson NA, Ismail N, Cohen C.

Open Forum Infect Dis. 2019 Mar 19;6(3):ofz020. doi: 10.1093/ofid/ofz020. eCollection 2019 Mar.

4.

Human bocavirus, coronavirus, and polyomavirus detected among patients hospitalised with severe acute respiratory illness in South Africa, 2012 to 2013.

Subramoney K, Hellferscee O, Pretorius M, Tempia S, McMorrow M, von Gottberg A, Wolter N, Variava E, Dawood H, Kahn K, Walaza S, Madhi SA, Cohen C, Venter M, Treurnicht FK.

Health Sci Rep. 2018 Jul 18;1(8):e59. doi: 10.1002/hsr2.59. eCollection 2018 Aug.

5.

The Fraction of Rhinovirus Detections Attributable to Mild and Severe Respiratory Illness in a Setting of High Human Immunodeficiency Virus Prevalence, South Africa, 2013-2015.

Hellferscee O, Treurnicht FK, Walaza S, Du Plessis M, Von Gottberg A, Wolter N, Moyes J, Dawood H, Variava E, Pretorius M, Venter M, Cohen C, Tempia S.

J Infect Dis. 2019 May 5;219(11):1697-1704. doi: 10.1093/infdis/jiy725.

PMID:
30590585
6.

Household Transmission of Seasonal Influenza From HIV-Infected and HIV-Uninfected Individuals in South Africa, 2013-2014.

Cohen C, Tshangela A, Valley-Omar Z, Iyengar P, Von Mollendorf C, Walaza S, Hellferscee O, Venter M, Martinson N, Mahlase G, McMorrow M, Cowling BJ, Treurnicht FK, Cohen AL, Tempia S.

J Infect Dis. 2019 Apr 19;219(10):1605-1615. doi: 10.1093/infdis/jiy702.

PMID:
30541140
7.

Quantifying how Different Clinical Presentations, Levels of Severity and Healthcare Attendance Shape the Burden of Influenza-Associated Illness: a Modeling Study from South Africa.

Tempia S, Walaza S, Moyes J, Cohen AL, McMorrow ML, Treurnicht FK, Hellferscee O, Wolter N, Gottberg AV, Nguweneza A, McAnerney JM, Dawood H, Variava E, Madhi SA, Cohen C.

Clin Infect Dis. 2018 Dec 2. doi: 10.1093/cid/ciy1017. [Epub ahead of print]

PMID:
30508065
8.

Prioritization of risk groups for influenza vaccination in resource limited settings - A case study from South Africa.

McMorrow ML, Tempia S, Walaza S, Treurnicht FK, Ramkrishna W, Azziz-Baumgartner E, Madhi SA, Cohen C.

Vaccine. 2019 Jan 3;37(1):25-33. doi: 10.1016/j.vaccine.2018.11.048. Epub 2018 Nov 22.

9.

Replacement of neuraminidase inhibitor-susceptible influenza A(H1N1) with resistant phenotype in 2008 and circulation of susceptible influenza A and B viruses during 2009-2013, South Africa.

Treurnicht FK, Buys A, Tempia S, Seleka M, Cohen AL, Walaza S, Glass AJ, Rossouw I, McAnerney J, Blumberg L, Cohen C, Venter M.

Influenza Other Respir Viruses. 2019 Jan;13(1):54-63. doi: 10.1111/irv.12611. Epub 2018 Oct 31.

10.

The Role of Human Immunodeficiency Virus in Influenza- and Respiratory Syncytial Virus-associated Hospitalizations in South African Children, 2011-2016.

McMorrow ML, Tempia S, Walaza S, Treurnicht FK, Moyes J, Cohen AL, Pretorius M, Hellferscee O, Wolter N, von Gottberg A, Nguweneza A, McAnerney JM, Naby F, Mekgoe O, Venter M, Madhi SA, Cohen C.

Clin Infect Dis. 2019 Feb 15;68(5):773-780. doi: 10.1093/cid/ciy532.

PMID:
29961814
11.

Performance of Surveillance Case Definitions in Detecting Respiratory Syncytial Virus Infection Among Young Children Hospitalized With Severe Respiratory Illness-South Africa, 2009-2014.

Rha B, Dahl RM, Moyes J, Binder AM, Tempia S, Walaza S, Bi D, Groome MJ, Variava E, Naby F, Kahn K, Treurnicht F, Cohen AL, Gerber SI, Madhi SA, Cohen C.

J Pediatric Infect Dis Soc. 2018 Jun 21. doi: 10.1093/jpids/piy055. [Epub ahead of print]

PMID:
29931284
12.

Influenza Viral Shedding in a Prospective Cohort of HIV-Infected and Uninfected Children and Adults in 2 Provinces of South Africa, 2012-2014.

von Mollendorf C, Hellferscee O, Valley-Omar Z, Treurnicht FK, Walaza S, Martinson NA, Lebina L, Mothlaoleng K, Mahlase G, Variava E, Cohen AL, Venter M, Cohen C, Tempia S.

J Infect Dis. 2018 Sep 8;218(8):1228-1237. doi: 10.1093/infdis/jiy310.

13.

Intra-host and intra-household diversity of influenza A viruses during household transmissions in the 2013 season in 2 peri-urban communities of South Africa.

Valley-Omar Z, Iyengar P, von Mollendorf C, Tempia S, Moerdyk A, Hellferscee O, Martinson N, McMorrow M, Variava E, Masonoke K, Cohen AL, Cohen C, Treurnicht FK.

PLoS One. 2018 May 24;13(5):e0198101. doi: 10.1371/journal.pone.0198101. eCollection 2018.

14.

Epidemiology and Molecular Identification and Characterization of Mycoplasma pneumoniae, South Africa, 2012-2015.

Carrim M, Wolter N, Benitez AJ, Tempia S, du Plessis M, Walaza S, Moosa F, Diaz MH, Wolff BJ, Treurnicht FK, Hellferscee O, Dawood H, Variava E, Cohen C, Winchell JM, von Gottberg A.

Emerg Infect Dis. 2018 Mar;24(3):506-513. doi: 10.3201/eid2403.162052.

15.

The effects of the attributable fraction and the duration of symptoms on burden estimates of influenza-associated respiratory illnesses in a high HIV prevalence setting, South Africa, 2013-2015.

Tempia S, Walaza S, Moyes J, Cohen AL, von Mollendorf C, McMorrow ML, Mhlanga S, Treurnicht FK, Venter M, Pretorius M, Hellferscee O, Wolter N, von Gottberg A, Nguweneza A, McAnerney JM, Dawood H, Variava E, Madhi SA, Cohen C.

Influenza Other Respir Viruses. 2018 May;12(3):360-373. doi: 10.1111/irv.12529. Epub 2018 Feb 1.

16.

In- and Out-of-hospital Mortality Associated with Seasonal and Pandemic Influenza and Respiratory Syncytial Virus in South Africa, 2009-2013.

Cohen C, Walaza S, Treurnicht FK, McMorrow M, Madhi SA, McAnerney JM, Tempia S.

Clin Infect Dis. 2018 Jan 6;66(1):95-103. doi: 10.1093/cid/cix740.

17.

Risk of Human Infections With Highly Pathogenic H5N2 and Low Pathogenic H7N1 Avian Influenza Strains During Outbreaks in Ostriches in South Africa.

Venter M, Treurnicht FK, Buys A, Tempia S, Samudzi R, McAnerney J, Jacobs CA, Thomas J, Blumberg L.

J Infect Dis. 2017 Sep 15;216(suppl_4):S512-S519. doi: 10.1093/infdis/jix018.

18.

The Burden and Clinical Presentation of Pulmonary Tuberculosis in Adults With Severe Respiratory Illness in a High Human Immunodeficiency Virus Prevalence Setting, 2012-2014.

Walaza S, Tempia S, Dreyer A, Dawood H, Variava E, Martinson NA, Moyes J, Cohen AL, Wolter N, von Mollendorf C, von Gottberg A, Haffejee S, Treurnicht F, Hellferscee O, Ismail N, Cohen C.

Open Forum Infect Dis. 2017 Aug 7;4(3):ofx116. doi: 10.1093/ofid/ofx116. eCollection 2017 Summer.

19.

Attributable Fraction of Influenza Virus Detection to Mild and Severe Respiratory Illnesses in HIV-Infected and HIV-Uninfected Patients, South Africa, 2012-2016.

Tempia S, Walaza S, Moyes J, Cohen AL, von Mollendorf C, McMorrow ML, Treurnicht FK, Venter M, Pretorius M, Hellferscee O, Wolter N, von Gottberg A, Nguweneza A, McAnerney JM, Dawood H, Variava E, Madhi SA, Cohen C.

Emerg Infect Dis. 2017 Jul;23(7):1124-1132. doi: 10.3201/eid2307.161959.

20.

Enterovirus genotypes among patients with severe acute respiratory illness, influenza-like illness, and asymptomatic individuals in South Africa, 2012-2014.

Hellferscee O, Tempia S, Walaza S, Variava E, Dawood H, Wolter N, Madhi SA, du Plessis M, Cohen C, Treurnicht FK.

J Med Virol. 2017 Oct;89(10):1759-1767. doi: 10.1002/jmv.24869. Epub 2017 Jul 6.

21.

Epidemiology of influenza B/Yamagata and B/Victoria lineages in South Africa, 2005-2014.

Seleka M, Treurnicht FK, Tempia S, Hellferscee O, Mtshali S, Cohen AL, Buys A, McAnerney JM, Besselaar TG, Pretorius M, von Gottberg A, Walaza S, Cohen C, Madhi SA, Venter M.

PLoS One. 2017 May 25;12(5):e0177655. doi: 10.1371/journal.pone.0177655. eCollection 2017.

22.

Risk Factors for Influenza-Associated Severe Acute Respiratory Illness Hospitalization in South Africa, 2012-2015.

Tempia S, Walaza S, Moyes J, Cohen AL, von Mollendorf C, Treurnicht FK, Venter M, Pretorius M, Hellferscee O, Mtshali S, Seleka M, Tshangela A, Nguweneza A, McAnerney JM, Wolter N, von Gottberg A, Dawood H, Variava E, Madhi SA, Cohen C.

Open Forum Infect Dis. 2017 Feb 10;4(1):ofw262. doi: 10.1093/ofid/ofw262. eCollection 2017 Winter.

23.

Development of a respiratory severity score for hospitalized adults in a high HIV-prevalence setting-South Africa, 2010-2011.

Millman AJ, Greenbaum A, Walaza S, Cohen AL, Groome MJ, Reed C, McMorrow M, Tempia S, Venter M, Treurnicht FK, Madhi SA, Cohen C, Variava E.

BMC Pulm Med. 2017 Feb 2;17(1):28. doi: 10.1186/s12890-017-0368-8.

24.

Enterovirus D68 and other enterovirus serotypes identified in South African patients with severe acute respiratory illness, 2009-2011.

Hellferscee O, Treurnicht FK, Tempia S, Variava E, Dawood H, Kahn K, Cohen AL, Pretorius M, Cohen C, Madhi SA, Venter M.

Influenza Other Respir Viruses. 2017 May;11(3):211-219. doi: 10.1111/irv.12444. Epub 2017 Feb 26.

25.

Severity of Respiratory Syncytial Virus Lower Respiratory Tract Infection With Viral Coinfection in HIV-Uninfected Children.

Mazur NI, Bont L, Cohen AL, Cohen C, von Gottberg A, Groome MJ, Hellferscee O, Klipstein-Grobusch K, Mekgoe O, Naby F, Moyes J, Tempia S, Treurnicht FK, Venter M, Walaza S, Wolter N, Madhi SA; South African Severe Acute Respiratory Illness (SARI) Surveillance Group.

Clin Infect Dis. 2017 Feb 15;64(4):443-450. doi: 10.1093/cid/ciw756. Erratum in: Clin Infect Dis. 2017 Jul 15;65(2):357.

26.

Estimating vaccine effectiveness in preventing laboratory-confirmed influenza in outpatient settings in South Africa, 2015.

McAnerney JM, Walaza S, Tempia S, Blumberg L, Treurnicht FK, Madhi SA, Valley-Omar Z, Cohen C.

Influenza Other Respir Viruses. 2017 Mar;11(2):177-181. doi: 10.1111/irv.12436. Epub 2016 Dec 20.

27.

Influenza vaccination of pregnant women protects them over two consecutive influenza seasons in a randomized controlled trial.

Mutsaerts E, Madhi SA, Cutland CL, Jones S, Hugo A, Trenor S, Treurnicht FK, Klipstein-Grobusch K, Weinberg A, Nunes MC.

Expert Rev Vaccines. 2016 Aug;15(8):1055-62. doi: 10.1080/14760584.2016.1192473. Epub 2016 Jun 6.

28.

The role of influenza, RSV and other common respiratory viruses in severe acute respiratory infections and influenza-like illness in a population with a high HIV sero-prevalence, South Africa 2012-2015.

Pretorius MA, Tempia S, Walaza S, Cohen AL, Moyes J, Variava E, Dawood H, Seleka M, Hellferscee O, Treurnicht F, Cohen C, Venter M.

J Clin Virol. 2016 Feb;75:21-6. doi: 10.1016/j.jcv.2015.12.004. Epub 2015 Dec 19.

29.

Legionnaires' Disease in South Africa, 2012-2014.

Wolter N, Carrim M, Cohen C, Tempia S, Walaza S, Sahr P, de Gouveia L, Treurnicht F, Hellferscee O, Cohen AL, Benitez AJ, Dawood H, Variava E, Winchell JM, von Gottberg A.

Emerg Infect Dis. 2016 Jan;22(1):131-3. doi: 10.3201/eid2201.150972.

30.

Parainfluenza Virus Infection Among Human Immunodeficiency Virus (HIV)-Infected and HIV-Uninfected Children and Adults Hospitalized for Severe Acute Respiratory Illness in South Africa, 2009-2014.

Cohen AL, Sahr PK, Treurnicht F, Walaza S, Groome MJ, Kahn K, Dawood H, Variava E, Tempia S, Pretorius M, Moyes J, Olorunju SA, Malope-Kgokong B, Kuonza L, Wolter N, von Gottberg A, Madhi SA, Venter M, Cohen C.

Open Forum Infect Dis. 2015 Sep 19;2(4):ofv139. doi: 10.1093/ofid/ofv139. eCollection 2015 Dec.

31.

Assessing the impact of pneumococcal conjugate vaccines on invasive pneumococcal disease using polymerase chain reaction-based surveillance: an experience from South Africa.

Tempia S, Wolter N, Cohen C, Walaza S, von Mollendorf C, Cohen AL, Moyes J, de Gouveia L, Nzenze S, Treurnicht F, Venter M, Groome MJ, Madhi SA, von Gottberg A.

BMC Infect Dis. 2015 Oct 26;15:450. doi: 10.1186/s12879-015-1198-z.

32.

Evaluation of influenza vaccine effectiveness and description of circulating strains in outpatient settings in South Africa, 2014.

McAnerney JM, Treurnicht F, Walaza S, Cohen AL, Tempia S, Mtshali S, Buys A, Blumberg L, Cohen C.

Influenza Other Respir Viruses. 2015 Jul;9(4):209-15. doi: 10.1111/irv.12314.

33.

Influenza vaccination of pregnant women and protection of their infants.

Madhi SA, Cutland CL, Kuwanda L, Weinberg A, Hugo A, Jones S, Adrian PV, van Niekerk N, Treurnicht F, Ortiz JR, Venter M, Violari A, Neuzil KM, Simões EA, Klugman KP, Nunes MC; Maternal Flu Trial (Matflu) Team.

N Engl J Med. 2014 Sep 4;371(10):918-31. doi: 10.1056/NEJMoa1401480.

34.

Genetic diversity and molecular epidemiology of human rhinoviruses in South Africa.

Pretorius MA, Tempia S, Treurnicht FK, Walaza S, Cohen AL, Moyes J, Hellferscee O, Variava E, Dawood H, Chhagan M, Haffjee S, Madhi SA, Cohen C, Venter M.

Influenza Other Respir Viruses. 2014 Sep;8(5):567-73. doi: 10.1111/irv.12264. Epub 2014 Jul 3.

35.

Epidemiology of influenza virus types and subtypes in South Africa, 2009-2012.

Cohen AL, Hellferscee O, Pretorius M, Treurnicht F, Walaza S, Madhi S, Groome M, Dawood H, Variava E, Kahn K, Wolter N, von Gottberg A, Tempia S, Venter M, Cohen C.

Emerg Infect Dis. 2014 Jul;20(7):1162-9. doi: 10.3201/eid2007.131869.

36.

Comparison of viral Env proteins from acute and chronic infections with subtype C human immunodeficiency virus type 1 identifies differences in glycosylation and CCR5 utilization and suggests a new strategy for immunogen design.

Ping LH, Joseph SB, Anderson JA, Abrahams MR, Salazar-Gonzalez JF, Kincer LP, Treurnicht FK, Arney L, Ojeda S, Zhang M, Keys J, Potter EL, Chu H, Moore P, Salazar MG, Iyer S, Jabara C, Kirchherr J, Mapanje C, Ngandu N, Seoighe C, Hoffman I, Gao F, Tang Y, Labranche C, Lee B, Saville A, Vermeulen M, Fiscus S, Morris L, Karim SA, Haynes BF, Shaw GM, Korber BT, Hahn BH, Cohen MS, Montefiori D, Williamson C, Swanstrom R; CAPRISA Acute Infection Study and the Center for HIV-AIDS Vaccine Immunology Consortium.

J Virol. 2013 Jul;87(13):7218-33. doi: 10.1128/JVI.03577-12. Epub 2013 Apr 24.

37.

Rapid, complex adaptation of transmitted HIV-1 full-length genomes in subtype C-infected individuals with differing disease progression.

Abrahams MR, Treurnicht FK, Ngandu NK, Goodier SA, Marais JC, Bredell H, Thebus R, de Assis Rosa D, Mlisana K, Seoighe C, Karim SA, Gray CM, Williamson C.

AIDS. 2013 Feb 20;27(4):507-18. doi: 10.1097/QAD.0b013e32835cab64. Erratum in: AIDS. 2013 Jun 1;27(9):1525.

38.

Vertical T cell immunodominance and epitope entropy determine HIV-1 escape.

Liu MK, Hawkins N, Ritchie AJ, Ganusov VV, Whale V, Brackenridge S, Li H, Pavlicek JW, Cai F, Rose-Abrahams M, Treurnicht F, Hraber P, Riou C, Gray C, Ferrari G, Tanner R, Ping LH, Anderson JA, Swanstrom R; CHAVI Core B, Cohen M, Karim SS, Haynes B, Borrow P, Perelson AS, Shaw GM, Hahn BH, Williamson C, Korber BT, Gao F, Self S, McMichael A, Goonetilleke N.

J Clin Invest. 2013 Jan;123(1):380-93. doi: 10.1172/JCI65330. Epub 2012 Dec 10.

39.

Increased memory differentiation is associated with decreased polyfunctionality for HIV but not for cytomegalovirus-specific CD8+ T cells.

Riou C, Treurnicht F, Abrahams MR, Mlisana K, Liu MK, Goonetilleke N, Koup R, Roederer M, Abdool Karim S, de Bruyn G, Williamson C, Gray CM, Burgers WA; CAPRISA 002 Study Team.

J Immunol. 2012 Oct 15;189(8):3838-47. doi: 10.4049/jimmunol.1201488. Epub 2012 Sep 10.

40.

CAPRISA 004 tenofovir microbicide trial: no impact of tenofovir gel on the HIV transmission bottleneck.

Valley-Omar Z, Sibeko S, Anderson J, Goodier S, Werner L, Arney L, Naranbhai V, Treurnicht F, Abrahams MR, Bandawe G, Swanstrom R, Karim QA, Karim SS, Williamson C.

J Infect Dis. 2012 Jul 1;206(1):35-40. doi: 10.1093/infdis/jis305. Epub 2012 May 2.

41.

Short communication decreased incidence of dual infections in South african subtype C-infected women compared to a cohort ten years earlier.

Woodman Z, Mlisana K, Treurnicht F, Abrahams MR, Thebus R, Karim SA, Williamson C; Caprisa Acute Infection Study Team.

AIDS Res Hum Retroviruses. 2011 Nov;27(11):1167-72. doi: 10.1089/AID.2010.0162. Epub 2011 Feb 9.

42.

Adaptive changes in HIV-1 subtype C proteins during early infection are driven by changes in HLA-associated immune pressure.

Treurnicht FK, Seoighe C, Martin DP, Wood N, Abrahams MR, Rosa Dde A, Bredell H, Woodman Z, Hide W, Mlisana K, Karim SA, Gray CM, Williamson C.

Virology. 2010 Jan 20;396(2):213-25. doi: 10.1016/j.virol.2009.10.002. Epub 2009 Nov 13.

43.

Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-poisson distribution of transmitted variants.

Abrahams MR, Anderson JA, Giorgi EE, Seoighe C, Mlisana K, Ping LH, Athreya GS, Treurnicht FK, Keele BF, Wood N, Salazar-Gonzalez JF, Bhattacharya T, Chu H, Hoffman I, Galvin S, Mapanje C, Kazembe P, Thebus R, Fiscus S, Hide W, Cohen MS, Karim SA, Haynes BF, Shaw GM, Hahn BH, Korber BT, Swanstrom R, Williamson C; CAPRISA Acute Infection Study Team; Center for HIV-AIDS Vaccine Immunology Consortium.

J Virol. 2009 Apr;83(8):3556-67. doi: 10.1128/JVI.02132-08. Epub 2009 Feb 4. Erratum in: J Virol. 2009 Jul;83(13):6974.

44.

Conserved positive selection signals in gp41 across multiple subtypes and difference in selection signals detectable in gp41 sequences sampled during acute and chronic HIV-1 subtype C infection.

Bandawe GP, Martin DP, Treurnicht F, Mlisana K, Karim SS, Williamson C; CAPRISA 002 Acute Infection Study Team.

Virol J. 2008 Nov 24;5:141. doi: 10.1186/1743-422X-5-141.

45.

Transmission of HIV-1 CTL escape variants provides HLA-mismatched recipients with a survival advantage.

Chopera DR, Woodman Z, Mlisana K, Mlotshwa M, Martin DP, Seoighe C, Treurnicht F, de Rosa DA, Hide W, Karim SA, Gray CM, Williamson C; CAPRISA 002 Study Team.

PLoS Pathog. 2008 Mar 21;4(3):e1000033. doi: 10.1371/journal.ppat.1000033.

46.

Neutralizing antibody responses in acute human immunodeficiency virus type 1 subtype C infection.

Gray ES, Moore PL, Choge IA, Decker JM, Bibollet-Ruche F, Li H, Leseka N, Treurnicht F, Mlisana K, Shaw GM, Karim SS, Williamson C, Morris L; CAPRISA 002 Study Team.

J Virol. 2007 Jun;81(12):6187-96. Epub 2007 Apr 4.

47.

Analysis of viral and genetic factors in South African patients with multiple sclerosis.

de Villiers JN, Treurnicht FK, Warnich L, Carr J, van Rensburg SJ, Kotze MJ.

Metab Brain Dis. 2006 Sep;21(2-3):163-9. Epub 2006 Jul 22.

PMID:
16865539
48.

Sequence analysis of near full-length HIV type 1 subtype D primary strains isolated in Cape Town, South Africa, from 1984 to 1986.

Loxton AG, Treurnicht F, Laten A, van Rensburg EJ, Engelbrecht S.

AIDS Res Hum Retroviruses. 2005 May;21(5):410-3.

PMID:
15929704
49.

Functionally-inactive and immunogenic Tat, Rev and Nef DNA vaccines derived from sub-Saharan subtype C human immunodeficiency virus type 1 consensus sequences.

Scriba TJ, zur Megede J, Glashoff RH, Treurnicht FK, Barnett SW, van Rensburg EJ.

Vaccine. 2005 Jan 19;23(9):1158-69.

PMID:
15629359
50.

Change in co-receptor usage of current South African HIV-1 subtype C primary isolates.

van Rensburg EJ, Smith TL, Zeier M, Robson B, Sampson C, Treurnicht F, Engelbrecht S.

AIDS. 2002 Dec 6;16(18):2479-80. No abstract available.

PMID:
12461424

Supplemental Content

Loading ...
Support Center